Pharmacoinvasive Management

Interventional Cardiology Clinics

Volumn 1, Issue 4, 2012, Pages 409-419

  Pakshirajan, Balaji ^a   Subban, Vijayakumar ^a   Mullasari, Ajit S ^a  

^a INSTITUTE OF CARDIOVASCULAR DISEASES   (India)

Author keywords

Primary percutaneous coronary intervention; ST segment elevation myocardial infarction; Thrombolysis; Total ischemic time

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

BLEEDING; CLINICAL EFFECTIVENESS; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84867217081     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2012.06.010     Document Type: Review

References (52)

1. Boden W.E., Eagle K., Granger C.B. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. J Am Coll Cardiol 2007, 50:917-929.
2. Eagle K.A., Goodman S.G., Avezum A., et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373-377.
3. Van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST segment elevation: the Task Force on the Management of ST Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
4. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003, 361:13-20.
5. The GUSTO Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial function. N Engl J Med 1993, 329:1615-1622.
6. Ndrepepa G., Mehilli J., Schulz S., et al. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol 2008, 52:512-517.
7. Scheller B., Hennen B., Hammer B., et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003, 42:634-641.
8. Francone M., Bucciarelli-Ducci C., Carbone I., et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009, 54:2145-2153.
9. Gersh B.J., Stone G.W., White H.D., et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA 2005, 293:979-986.
10. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996, 348:771-775.
11. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004, 109:1223-1225.
12. The European Myocardial Infarction Project Group Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993, 329:383-389.
13. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003, 42:991-997.
14. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2008, 51:210-247.
15. Silber S., Albertsson P., Fernandez-Aviles F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005, 26:804-847.
16. Nielsen P.H., Maeng M., Busk M., et al. Primary angioplasty versus fibrinolysis in acute myocardial infarction, long-term follow-up in the Danish Acute Myocardial Infarction 2 trial. Circulation 2010, 121:1484-1491.
17. Steg P.G., Bonnefoy E., Chabaud S., et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003, 108:2851-2856.
18. Widimský P., Budesínský T., Vorác D., 'PRAGUE' Study Group Investigators, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicenter trial 'PRAGUE-2'. Eur Heart J 2003, 23:94-104.
19. Nallamothu B.K., Bates E.R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol 2003, 92:824-826.
20. Fibrinolytic Therapy Trialist (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343:311-322.
21. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002, 360:825-829.
22. Morrison L., Verbeek P., McDonald A., et al. Mortality and pre-hospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA 2000, 283:2686-2692.
23. Danchin N., Durand E., Blanchard D. Pre-hospital thrombolysis in perspective. Eur Heart J 2008, 29:2835-2842.
24. Bonnefoy E., Steg P.G., Bouititie F., for the CAPTIM Investigators, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009, 30:1598-1606.
25. Sutton A.G., Campbell P.G., Graham R., et al. A randomized trial of rescue angioplasty versus conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit Infarction (MERLIN) trial. J Am Coll Cardiol 2004, 44:287-296.
26. Gershlick A.H., Stephens-Lloyd A., Hughes S., et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005, 353:2758-2768.
27. Sutton A.G., Campbell P.G., Graham R., et al. One year results of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) trial. Heart 2005, 91:1330-1337.
28. Wijeysundera H.C., Vijayaraghavan R., Nallamothu B.K., et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007, 49:422-430.
29. Keeley E.C., Boura J.A., Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006, 367:579-588.
30. Collet J.P., Montalescot G., Le May M., et al. Percutaneous coronary intervention after fibrinolysis: a multiple metaanalyses approach according to the type of strategy. J Am Coll Cardiol 2006, 48:1326-1335.
31. Kiernan T.J., Ting H.H., Gersh B.J. Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls. Eur Heart J 2007, 28:1545-1553.
32. Assessment of the Safety, and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006, 367:569-578.
33. Ellis S.G., Tendera M., de Belder M.A., et al. Facilitated PCI in patients with ST-segment elevation myocardial infarction. N Engl J Med 2008, 358:2205-2217.
34. Kushner F.G., Hand M., Smith S.C., et al. 2009 focused updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 120:2271-2306.
35. Ross A.M., Coyne K.S., Reiner J.S., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT Investigators. Plasminogen- Activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999, 34:1954-1962.
36. Brodie B.R., Stuckey T.D., Hansen C., et al. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000, 85:13-18.
37. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation 2001, 104:636-641.
38. De Luca G., Ernst N., Zijlstra F., et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2004, 43:1363-1367.
39. Cantor W.J., Fitchett D., Borgundvaag B., et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360:2705-2718.
40. Widimsky P., Groch L., Zelizko M., et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000, 21:823-831.
41. Bednar F., Widimsky P., Krupicka J., et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE- 1 study). Can J Cardiol 2003, 19:1133-1137.
42. Fernandez-Avilés F., Alonso J.J., Castro-Beiras A., et al. Routine invasive strategy within 24 hours of thrombolysis versus an ischaemia guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet 2004, 364:1045-1053.
43. So D.Y., Ha A.C., Davies R.F., et al. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial. Can J Cardiol 2010, 26:e7-e12.
44. Armstrong P.W., WEST Steering Committee A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006, 27:1530-1538.
45. Di Mario C., Dudek D., Piscione F., et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008, 371:559-568.
46. Bohmer E., Hoffmann P., Abdelnoor M., et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2010, 55:102-110.
47. Armstrong P.W., Gershlick A., Goldstein P., STREAM Steering Committee, et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. Am Heart J 2010, 160:30-35.
48. Borgia F., Goodman S.G., Halvorsen S., et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 2010, 31:2156-2169.
49. D'Souza S.P., Mamas M.A., Fraser D.G., et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J 2011, 32:972-982.
50. Bogaty P., Filion K.B., Brophy J.M. Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trials. BMC Cardiovasc Disord 2011, 11:34. Available at:, Accessed February 12, 2012. http://www.%20biomedcentral.com/1471-2261/11/34.
51. Levine G.N., Bates E.R., Blankenship J.C., et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011, 58:e44-e122.
52. Wijns W., Kolh P., Danchin N., Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), et al. Guidelines on myocardial revascularization. Eur Heart J 2010, 31:2501-2555.